Editorial
doi: 10.1046/j.1525-1497.1997.07147.x.
Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?
- PMID: 9294792
- PMCID: PMC1497168
- DOI: 10.1046/j.1525-1497.1997.07147.x
Item in Clipboard
Editorial
Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?
J Gen Intern Med.
1997 Sep.
No abstract available
Comment on
-
Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.J Gen Intern Med. 1997 Sep;12(9):523-30. doi: 10.1046/j.1525-1497.1997.07105.x. J Gen Intern Med. 1997. PMID: 9294785 Free PMC article.
-
Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.J Gen Intern Med. 1997 Sep;12(9):563-6. doi: 10.1046/j.1525-1497.1997.07110.x. J Gen Intern Med. 1997. PMID: 9294790 Free PMC article.
Similar articles
-
Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.J Gen Intern Med. 1997 Sep;12(9):563-6. doi: 10.1046/j.1525-1497.1997.07110.x. J Gen Intern Med. 1997. PMID: 9294790 Free PMC article.
-
Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?Int J Cardiol. 1997 Mar;59(1):7-10. doi: 10.1016/s0167-5273(96)02904-x. Int J Cardiol. 1997. PMID: 9080020
-
Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.J Gen Intern Med. 1997 Sep;12(9):523-30. doi: 10.1046/j.1525-1497.1997.07105.x. J Gen Intern Med. 1997. PMID: 9294785 Free PMC article.
-
Angiotensin converting enzyme inhibition in heart failure: clinical trials and clinical practice.Cardiovasc Drugs Ther. 2002 Jan;16(1):67-74. doi: 10.1023/a:1015375717044. Cardiovasc Drugs Ther. 2002. PMID: 12085981 Review.
-
Diagnosis and management of chronic heart failure: how to reestablish a key role for the primary care physician?Acta Clin Belg. 2004 Sep-Oct;59(5):300-3. doi: 10.1179/acb.2004.044. Acta Clin Belg. 2004. PMID: 15641401 Review. No abstract available.
Cited by
-
Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis.Drugs Aging. 2010 Oct 1;27(10):845-54. doi: 10.2165/11539340-000000000-00000. Drugs Aging. 2010. PMID: 20883064
References
-
- American College of Cardiology/American Heart Association Task Force on Practice Guidelines Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376–98. - PubMed
-
- The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293–302. - PubMed
-
- The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 1992;327:686–91. - PubMed
-
- Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669–77. - PubMed
-
- Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the registry of studies of left ventricular dysfunction (SOLVD) South Med J. 1995;88:514–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical